Most lately, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger https://janep986suw8.blogdeazar.com/profile